$RMD - Resmed making a comeback

$RMD - Resmed making a comeback?

Increasing obesity and associated sleep apnea should further the demand for their products.

Might be a good one for longer term buy and hold like SMSF.

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.

Komentarz:

Performing nicely. Bit of volume coming through.

Komentarz:

Continuing its run

Komentarz:

Ran nicely up to $16.59 then fell off a cliff with earnings report. I got out around $16.34 so took some nice profit. It looks like it is recovering nicely so looking for another entry.

Komentarz:

12% Trail would have kept you in this for the year for a 70% to 80% gain.